These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8114845)

  • 21. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 24. ["How must deep leg venous thrombosis be diagnosed and treated?"].
    Bruhn HD
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673
    [No Abstract]   [Full Text] [Related]  

  • 25. [Venous thrombosis. After heparin administration, low-molecular-weight heparin for prevention of recurrence].
    MMW Fortschr Med; 2001 Apr; 143(16):56. PubMed ID: 11367997
    [No Abstract]   [Full Text] [Related]  

  • 26. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose heparin prophylaxis of deep-vein thrombosis.
    Med Lett Drugs Ther; 1973 Apr; 15(8):35. PubMed ID: 4696226
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current indications of low-molecular-weight heparins].
    Vignes S; Meyer G; Marjanovic Z; Farge-Bancel D
    Ann Med Interne (Paris); 1997; 148(2):154-62. PubMed ID: 9238441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparin (fraxiparine) to prevent deep vein thrombosis in patients undergoing orthopedic surgery: a clinical report of two regimens.
    Drouet JC; Bernard JM; Bourreli B; Gunst JP
    Haemostasis; 1988; 18(2):135-6. PubMed ID: 2842239
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in the prophylaxis of deep venous thrombosis: a profile of embolex. Proceedings of a scientific symposium. May 3, 1985, New York City.
    Pharmacotherapy; 1986; 6(4 Pt 2):1S-29S. PubMed ID: 3774564
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
    Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
    Arch Intern Med; 1997 Feb; 157(3):289-94. PubMed ID: 9040295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prophylaxis of venous thrombosis and low-molecular-weight heparin].
    Vallano A; Arnau JM; Vallés JA
    Med Clin (Barc); 1991 Sep; 97(7):272-5. PubMed ID: 1658499
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of iliofemoral thrombosis in a pregnant patient with heparin resistance.
    Anand SS; Brimble S; Ginsberg JS
    Arch Intern Med; 1997 Apr; 157(7):815-6. PubMed ID: 9125015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparin for the treatment of deep vein thrombosis.
    Thompson-Ford JK
    Pharmacotherapy; 1998; 18(4):748-58. PubMed ID: 9692649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
    Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
    Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients.
    Bacher P; Horst B; Breyer HG; Hoppensteadt DA; Walenga JM; Fareed J
    Semin Thromb Hemost; 1993; 19 Suppl 1():73-8. PubMed ID: 8395735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of thrombosis in minimally invasive surgery].
    Harenberg J
    Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.